Lasmotinib, CAS [[2127107-15-5]]

Product Overview

• Article Name: Lasmotinib, CAS [[2127107-15-5]]
• Biozol Catalog Number: MCE-HY-153857
• Supplier Catalog Number: HY-153857
• Alternative Catalog Number: MCE-HY-153857-100MG,MCE-HY-153857-5MG,MCE-HY-153857-50MG,MCE-HY-153857-10MG,MCE-HY-153857-1MG,MCE-HY-153857-25MG,MCE-HY-153857-10MMX1ML
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: PHI-101

Product Description

Lasmotinib (PHI-101) is a FLT3 and CHK2 inhibitor. Lasmotinib potently inhibits FLT3 single activating mutations (ITD or TKD mutants) and has inhibitory activity against FLT3 double (ITD/D835Y or ITD/F691L) and triple (ITD/D835Y/F691L) resistance mutations. Lasmotinib synergizes with Venetoclax (HY-15531) or Azacytidine to inhibit leukemia. Lasmotinib exhibits anticancer activity against ovarian and breast cancer[1][2][3][4].

Product Properties

• Molecular Weight: 386.44
• Purity: 98.97
• CAS Number: [2127107-15-5]
• Formula: C19H19FN4O2S
• Target: Checkpoint Kinase (Chk),FLT3

Application Notes

• Application Notes: Reference compound